B

Bide Pharmatech Co Ltd
SSE:688073

Watchlist Manager
Bide Pharmatech Co Ltd
SSE:688073
Watchlist
Price: 70.31 CNY -1.84% Market Closed
Market Cap: 6.4B CNY

Wall Street
Price Targets

Price Targets Summary
Bide Pharmatech Co Ltd

There are no price targets for Bide Pharmatech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bide Pharmatech Co Ltd Competitors:
Price Targets
002332
Zhejiang Xianju Pharmaceutical Co Ltd
29% Upside
OCS
Oculis Holding AG
78% Upside
SNDL
Sundial Growers Inc
255% Upside
AMRX
Amneal Intermediate Inc
10% Upside
ANCR
Animalcare Group PLC
29% Upside

Revenue
Forecast

Revenue Estimate
Bide Pharmatech Co Ltd

For the last 4 years the compound annual growth rate for Bide Pharmatech Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 20%.

30%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bide Pharmatech Co Ltd

Operating Income forecast
is not available for
Bide Pharmatech Co Ltd

Net Income
Forecast

Net Income Estimate
Bide Pharmatech Co Ltd

For the last 4 years the compound annual growth rate for Bide Pharmatech Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 32%.

19%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Bide Pharmatech Co Ltd's stock price target?
Not Available

Bide Pharmatech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Bide Pharmatech Co Ltd's Revenue forecast?
Projected CAGR
20%

For the last 4 years the compound annual growth rate for Bide Pharmatech Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 20%.

What is Bide Pharmatech Co Ltd's Net Income forecast?
Projected CAGR
32%

For the last 4 years the compound annual growth rate for Bide Pharmatech Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 32%.

Back to Top